| |
|
|
 |
|
print
|
|
|
|
|
State-of-the-Art Facilities |
| | Our cutting-edge facilities and broad technology experience means we can offer a full range of cGMP production strategies depending on your peptide’s structural complexity. Additionally, we have a broad array of synthesis, purification, isolation, and analytical equipment as well as support infrastructure to find an optimal solution for your immediate and long-term peptide needs. |
Europe
Braine, Belgium
Solid-phase and liquid-phase technology
Kouřim, Czech Republic
Recombinant DNA technology
Visp, Switzerland
Solid-phase, liquid-phase and recombinant DNA technology
Asia
Nansha, China
Solid-phase and liquid-phase technology
Upstream & Downstream Equipment
Solid-Phase
− Synthesizers from 50mL to 1 600L
− Cleavage systems
Liquid-Phase
− Vessel sizes range from 10L to 2 800L
− Cyclization lines
Recombinant DNA Technology
− Microbial production in vessels from 15m3 to 75m3
|
|
|
|
|
|
|
|
|
 |
